Breaking News Instant updates and real-time market news.

Big Lots to host analyst and investor meeting

Analyst and Investor meeting to be held in Columbus on September 19 at 8:30 am. Webcast Link

19

Sep

27

Sep

BIGBig Lots

$49.05

-0.97 (-1.94%)

07/25/17

DBAB

07/25/17UPGRADETarget $56DBABBuy

Big Lots upgraded to Buy from Hold at Deutsche Bank

Deutsche Bank analyst Paul Trussell upgraded Big Lots to Buy and raised his price target for the shares to $56 from $55. The current valuation is "compelling" given the disconnect between the company's "impressive" operating profit growth and multiple, Trussell tells investors in a research note. He sees the company's analyst day in September as a potential catalyst.

07/25/17

DBAB

07/25/17DOWNGRADETarget $17DBABSell

Under Armour downgraded to Sell from Hold at Deutsche Bank

Deutsche Bank analyst Paul Trussell downgraded Under Armour (UAA) to Sell with an unchanged price target of $17. The performance apparel maker closed yesterday down 37c to $20.27. The analyst says a "difficult and promotional selling environment along with segmentation challenges" weaken his confidence in the company's near-term results. Even amid weak investor sentiment, Under Armour won't get a pass on potentially weak Q2 results, Trussell tells investors in a research note. He views the company's growth story as "challenged" and questions the "expensive" valuation. The analyst this morning also upgraded DSW (DSW) and Big Lots (BIG) to Buy.

07/25/17

07/25/17UPGRADE

On The Fly: Top five analyst upgrades

Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Mondelez (MDLZ) upgraded to Overweight from Neutral at Piper Jaffray with analyst Michael Lavery saying favorable sugar and cocoa costs provide a boost to margins. 2. Big Lots (BIG) upgraded to Buy from Hold at Deutsche Bank analyst Paul Trussell saying the current valuation is "compelling" given the disconnect between the company's "impressive" operating profit growth and multiple. 3. Werner (WERN) upgraded to Neutral from Underperform at BofA/Merrill with analyst Ken Hoexter saying truckload utilization and rates are turning positive. 4. Atlassian (TEAM) upgraded to Overweight from Equal Weight at Morgan Stanley with analyst Sanjit Singh saying has increased confidence in expansion trends of the user base and said there are clear signs of pricing power, supporting 30% topline growth and 40% free cash flow CAGR over the next 3 years. 5. DSW (DSW) upgraded to Buy from Hold at Deutsche Bank with analyst Paul Trussell saying the shares offer an "intriguing non-apparel value play." This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

08/30/17

LOOP

08/30/17NO CHANGETarget $64LOOPBuy

Big Lots should consider going private, says Loop Capital

Loop Capital analyst Anthony Chukumba said he believes Big Lots would be attractive to private equity sponsors, that current leveraged finance market conditions would support such a transaction, and that the company should consider going private given the "lack of respect" that its sizeable discount to its peers indicates. A leveraged buyout at $60 per share could be financed and would generate returns "comfortably above" those that private equity firms typically target, he tells investors, adding that he has "no reason to believe a deal is imminent." Chukumba keeps a Buy rating and $64 price target on Big Lots shares.

UP AFTER EARNINGS: Cintas (CTAS), up 2.9%... Micron (MU), up 2.8%. ALSO HIGHER: Editas Medicine (EDIT), up 3.1% after it received the EMA's orphan medicinal product designation for EDIT-101... Twitter (TWTR), up 1.8% after it said it will start testing longer, 280-character tweets with a small group. DOWN AFTER EARNINGS: Nike (NKE), down 3.2%. ALSO LOWER: Kornit Digital (KRNT), down 12.2% after it cut its third quarter revenue guidance... Westlake Chemical Partners (WLKP), down 8.3% after it filed to sell 4.5M units for limited partners... Intra-Cellular (ITCI), down 7.2% after it filed to sell $150M in common stock... Ascendis Pharma (ASND), down 4.3% after it announced an offering of $125M of ADSs.